ArticleExperimental neurology2025
Overexpression of endothelial β4 integrin has no impact on blood-brain barrier integrity or the pathogenesis of experimental autoimmune encephalomyelitis.
Article in Experimental neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Laminin is a major component of the vascular basement membrane and transgenic mice deficient in astrocyte or pericyte laminin manifest blood-brain barrier (BBB) disruption, implying an important stabilizing role for laminin in BBB integrity. As the laminin receptor α6β4 integrin is strongly induced on CNS blood vessels in the neuroinflammatory animal model experimental autoimmune encephalomyelitis (EAE), and mice deficient in endothelial β4 integrin (β4-EC-KO) display worse EAE, here we tested in a novel transgenic knock-in mouse, whether constitutive overexpression of endothelial β4 integrin (β4-EC-KI) would enhance BBB integrity and reduce EAE development and progression. In immunofluorescent analysis of brain and spinal cord tissue, β4-EC-KI mice showed strong constitutive endothelial β4 integrin expression in all blood vessels, along with upregulation of its α6 integrin subunit partner and the α4 subunit of its physiological ligand, laminin 411. Under disease-free conditions, vascular structure and activation were unchanged in β4-EC-KI mice. In the EAE model, β4-EC-KI mice were no different from wild-type littermate controls in the time of onset, peak clinical score, or progression of EAE. Consistent with this, histopathological analysis revealed no observable differences in levels of BBB disruption, vascular activation, leukocyte infiltration, endothelial tight junction protein expression, or microglial and astrocyte activation. These data demonstrate that while β4-EC-KI mice show strong constitutive expression of endothelial β4 integrin, this had no discernible impact on blood-brain barrier integrity or the pathogenesis of EAE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.